TGTX:NASDAQ
TG Therapeutics Inc common stock
$53.04
arrow_downward
-1.78%(-0.96) 1D
$52.81
arrow_downward
-0.43% (-0.23)bedtimeAfter hours
Closed: Sep 15, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TGTX...
Open
$53.59
High
$54.41
Low
$52.50
Mkt. cap
8.12B
Avg. vol.
2.02M
Volume
1.76M
P/E ratio
19.32
52-wk high
$59.30
52-wk low
$26.76
EPS
$2.75
Beta
1.67
Shares outstanding
153.07M
No. of employees
399
Open
$53.59
High
$54.41
Low
$52.50
Mkt. cap
8.12B
Avg. vol.
2.02M
Volume
1.76M
P/E ratio
19.32
52-wk high
$59.30
52-wk low
$26.76
EPS
$2.75
Beta
1.67
Shares outstanding
153.07M
No. of employees
399
News stories
From web sources and news partners
Benzinga
·
7 hours ago
Insider Decision: Laurence N Charney Offloads $274K Worth Of TG Therapeutics Stock
Stock Titan
·
1 day ago
Tax-related share sale by TG Therapeutics (TGTX) director
Investing.com UK
·
1 day ago
TG Therapeutics at H.C. Wainwright: BRIUMVI gains momentum By Investing.com
About TG Therapeutics Inc common stock
CEOMichael S Weiss
Employees399
Founded1993
HeadquartersMorrisville, North Carolina, United States
SectorBiotechnology
Websitetgtherapeutics.com